Cancer stem cells switch on tumor neovascularization

Current Molecular Medicine

Volumn 11, Issue 1, 2011, Pages 69-75

  Ping, Y F ^a   Bian, X W ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Cancer stem cells; Microvascular niches; Transdifferentiation; Vasculogenic mimicry

Indexed keywords

CANCER INVASION; CANCER RESEARCH; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INTERACTION; CELL POPULATION; ENDOTHELIUM CELL; HUMAN; NONHUMAN; REVIEW; TUMOR RECURRENCE; TUMOR VASCULARIZATION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CELL TRANSDIFFERENTIATION; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR MICROENVIRONMENT;

EID: 79551676410     PISSN: 15665240     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652411794474383     Document Type: Review

References (71)

1. Furth J, Kahn M. The transmission of leukaemia of mice witha single cell. Am J Cancer 1937; 31: 276-82.
2. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating humanacute myeloid leukaemia after transplantation into SCIDmice. Nature 1994; 367: 645-8.
3. Bonnet D, Dick JE. Human acute myeloid leukaemia isorganized as a hierarchy that originates from a primitivehematopoietic cell. Nat Med 1997; 3: 730-7.
4. Liu H, Patel MR, Prescher JA, et al. Cancer stem cells fromhuman breast tumors are involved in spontaneousmetastases in orthotopic mouse models. Proc Natl Acad Sci USA 2010; 107: 18115-20.
5. Rausch V, Liu L, Kallifatidis G, et al. Synergistic activity ofsorafenib and sulforaphane abolishes pancreatic cancerstem cell characteristics. Cancer Res 2010; 70: 5004-13.
6. Boiko AD, Razorenova OV, van de Rijn M, et al. Humanmelanoma-initiating cells express neural crest nerve growthfactor receptor CD 271. Nature 2010; 466: 133-7.
7. Liao CP, Adisetiyo H, Liang M, Roy-Burman P. Cancerassociatedfibroblasts enhance the gland-forming capabilityof prostate cancer stem cells. Cancer Res 2010; 70: 7294-303.
8. Song J, Chang I, Chen Z, Kang M, Wang CY. Characterization of side populations in HNSCC: highlyinvasive, chemoresistant and abnormal Wnt signaling. PLoSOne 2010; 5: e11456.
9. Lombardo Y, Scopelliti A, Cammareri P, et al. BMP4 inducesdifferentiation of colorectal cancer stem cells and increasestheir response to chemotherapy in mice. Gastroenterology 2010; doi: 10.1053/j.gastro.2010.10.005.
10. Wang B, Yu SC, Jiang JY, et al. An Inhibitor of Arachidonate5-Lipoxygenase, Nordy, Induces Differentiation and Inhibits Self-Renewal of Glioma Stem-Like Cells. Stem Cell Rev 2010; doi: 10.1007/s 12015-010-9175-9.
11. Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cellsperspectiveson current status and future directions: AACRworkshop on cancer stem cells. Cancer Res 2006; 66: 9339-44.
12. Jin F, Zhao L, Zhao HY, et al. Comparison between cells andcancer stem-like cells isolated from glioblastoma andastrocytoma on expression of anti-apoptotic and multidrugresistance-associated protein genes. Neuroscience 2008; 154: 541-50.
13. Cortes-Dericks L, Carboni GL, Schmid RA, Karoubi G. Putative cancer stem cells in malignant pleural mesotheliomashow resistance to cisplatin and pemetrexed. Int J Oncol 2010; 37: 437-44.
14. Cammareri P, Scopelliti A, Todaro M, et al. Aurora-a isessential for the tumorigenic capacity and chemoresistanceof colorectal cancer stem cells. Cancer Res 2010; 70: 4655-65.
15. Hirschmann-Jax C, Foster AE, Wulf GG, et al. A distinct''side population'' of cells with high drug efflux capacity inhuman tumor cells. Proc Natl Acad Sci USA 2004; 101: 14228-33.
16. + cancer stem cells inglioblastoma. Mol Cancer 2006; 5: 67.
17. Bao S, Wu Q, McLendon RE, et al. Glioma stem cellspromote radioresistance by preferential activation of the DNAdamage response. Nature 2006; 444: 756-60.
18. -breast cancer cells exhibit enhanced invasive properties: anearly step necessary for metastasis. Breast Cancer Res 2006; 8: R59.
19. Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S. Stem cell and epithelial-mesenchymal transitionmarkers are frequently overexpressed in circulating tumorcells of metastatic breast cancer patients. Breast Cancer Res 2009; 11: R46.
20. Narazaki M, Tosato G. Tumor cell populations differ inangiogenic activity: a model system for spontaneousangiogenic switch can tell us why. J Natl Cancer Inst 2006; 98: 294-5.
21. Hanahan D, Folkman J. Patterns and emerging mechanismsof the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-64.
22. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelialgrowth factor induced by hypoxia may mediate hypoxiainitiatedangiogenesis. Nature 1992; 359: 843-5.
23. Shing Y, Folkman J, Haudenschild C, Lund D, Crum R, Klagsbrun M. Angiogenesis is stimulated by a tumor-derivedendothelial cell growth factor. J Cell Biochem 1985; 29: 275-87.
24. Cavallo T, Sade R, Folkman J, Cotran RS. Tumorangiogenesis. Rapid induction of endothelial mitosesdemonstrated by autoradiography. J Cell Biol 1972; 54: 408-20.
25. Komarovaa NL, Mironov V. On the role of endothelialprogenitor cells in tumor neovascularization. J Theor Biol 2005; 235: 338-49.
26. Bian XW, Chen JH, Jiang XF, Bai JS, Wang QL, Zhang X. Angiogenesis as an immunopharmacologic target ininflammation and cancer. Int Immunopharmacol 2004; 4: 1537-47.
27. Gilad AA, Israely T, Dafni H, Meir G, Cohen B, Neeman M. Functional and molecular mapping of uncoupling betweenvascular permeability and loss of vascular maturation inovarian carcinoma xenografts: the role of stroma cells intumor angiogenesis. Int J Cancer 2005; 117: 202-11.
28. Saarinen NM, Abrahamsson A, Dabrosin C. Estrogeninducedangiogenic factors derived from stromal and cancercells are differently regulated by enterolactone and genisteinin human breast cancer in vivo. Int J Cancer 2010; 127: 737-45.
29. Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitropropagation of tumorigenic breast cancer cells withstem/progenitor cell properties. Cancer Res 2005; 65: 5506-11.
30. Bao S, Wu Q, Sathornsumetee S, et al. Stem cell-like gliomacells promote tumor angiogenesis through vascularendothelial growth factor. Cancer Res 2006; 66: 7843-48.
31. Pellegatta S, Poliani PL, Corno D, et al. Neurospheresenriched in cancer stem-like cells are highly effective ineliciting a dendritic cell-mediated immune response againstmalignant gliomas. Cancer Res 2006; 66: 10247-52.
32. Folkins C, Shaked Y, Man S, et al. Glioma tumor stem celllikecells promote tumor angiogenesis and vasculogenesisvia vascular endothelial growth factor and stromal-derivedfactor 1. Cancer Res 2009; 69: 7243-51.
33. Yao XH, Ping YF, Chen JH, et al. Glioblastoma stem cellsproduce vascular endothelial growth factor by activation of aG-protein coupled formlpeptide receptor FPR. J Pathol 2008; 215: 369-76.
34. Oka N, Soeda A, Inagaki A, et al. VEGF promotestumorigenesis and angiogenesis of human glioblastoma stemcells. Biochem Biophys Res Commun 2007; 360: 553-9.
35. Salmaggi A, Bolardi A, Gelati M, et al. Glioblastoma-derivedtumorospheres identify a population of tumor stem-like cellswith angiogenic potential and enhanced multidrug resistancephenotype. Glia 2006; 54: 850-60.
36. Ehtesham M, Mapara KY, Stevenson CB, Thompson RC. CXCR4 mediates the proliferation of glioblastoma progenitorcells. Cancer Lett 2009; 274: 305-12.
37. Krohn A, Song YH, Muehlberg F, Droll L, Beckmann C, Alt E. CXCR4 receptor positive spheroid forming cells areresponsible for tumor invasion in vitro. Cancer Lett 2009; 280: 65-71.
38. Ping YF, Yao XH, Bian XW, et al. Activation of CXCR4 inhuman glioma stem cells promotes tumor angiogenesis. Zhonghua Bing Li Xue Za Zhi 2007; 36: 179-83.
39. Sakariassen P, Prestegarden L, Wang J, et al. Angiogenesisindependenttumor growth mediated by stem-like cancercells. Proc Natl Acad Sci USA 2006; 103: 16466-71.
40. Streubel B, Chott A, Huber D, et al. Lymphoma-specificgenetic aberrations in microvascular endothelial cells in Bcelllymphomas. N Engl J Med 2004; 351: 250-9.
41. Rigolin GM, Fraulini C, Ciccone M, et al. Neoplasticcirculating endothelial cells in multiple myeloma with 13q 14deletion. Blood 2006; 107: 2531-5.
42. Fonsato V, Buttiglieri S, Deregibus MC, Puntorieri V, Bussolati B, Camussi G. Expression of Pax2 in human renaltumor-derived endothelial cells sustains apoptosis resistanceand angiogenesis. Am J Pathol 2006; 168: 706-13.
43. Pezzolo A, Parodi F, Corrias MV, Cinti R, Gambini C, Pistoia V. Tumor origin of endothelial cells in human neuroblastoma. J Clin Oncol 2007; 25: 376-83.
44. Ribatti D, Nico B, Pezzolo A, et al. Angiogenesis in a humanneuroblastoma xenograft model: mechanisms and inhibitionby tumor-derived interferon-gamma. Br J Cancer 2006; 94: 1845-52.
45. Hendrix MJ, Seffor RE, Seftor EA, et al. Transendothelialfunction of human metastatic melanoma cells: role of themicroenvironment in cell-fate determination. Cancer Res 2002; 62: 665-8.
46. Bruno S, Bussolati B, Grange C, et al. CD 133+ renalprogenitor cells contribute to tumor angiogenesis. Am JPathol 2006; 169: 2223-35.
47. Kusumbe AP, Mali AM, Bapat SA. CD 133 expressing stemcells associated with ovarian metastases establish anendothelial hierarchy and contribute to tumor vasculature. Stem Cells 2009; 27: 498-508.
48. Shen R, Ye Y, Chen L, Yan Q, Barsky SH, Gao JX. Precancerous stem cells can serve as tumor vasculogenicprogenitors. PLoS One 2008; 3: e1652.
49. Chen L, Shen R, Ye Y, et al. Precancerous stem cells havethe potential for both benign and malignant differentiation. PLoS One 2007; 2: e293.
50. Bussolati B, Grange C, Sapino A, Camussi G. Endothelialcell differentiation of human breast tumor stem/progenitorcells. J Cell Mol Med 2009; 13: 309-19.
51. Bussolati B, Bruno S, Gristina G, Ferrando U, Camussi G. Identification of a tumor-initiating stem cell population inhuman renal carcinomas. FASEB J 2008; 22: 3696-705.
52. Alvero AB, Fu HH, Holmberg J, et al. Stem-like ovariancancer cells can serve as tumor vascular progenitors. Stem Cells 2009; 27: 2405-13.
53. Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Vasculogenicmimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer 2003; 3: 411-21.
54. Bittner M, Meltzer P, Chen Y, et al. Molecular classification ofcutaneous malignant melanoma by gene expressionprofiling. Nature 2000; 406: 536-40.
55. Maniotis AJ, Folberg R, Hess A, et al. Vascular channelformation by human melanoma cells in vivo and in vitro:vasculogenic mimicry. Am J Pathol 1999; 155: 739-52.
56. Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicryand tumor angiogenesis. Am J Pathol 2000; 156: 361-81.
57. Seftor EA, Meltzer PS, Kirschmann DA, et al. Moleculardeterminants of human uveal melanoma invasion andmetastasis. Clin Exp Metastasis 2002; 19: 233-46.
58. Seftor EA, Meltzer PS, Schatteman GC, et al. Expression ofmultiple molecular phenotypes by aggressive melanomatumor cells: role in vasculogenic mimicry. Crit Rev Oncol Hematol 2002; 44: 17-27.
59. Monzani E, La Porta CA. Targeting cancer stem cells tomodulate alternative vascularization mechanisms. Stem Cell Rev 2008; 4: 51-6.
60. Folberg R, Arbieva Z, Moses J, et al. Tumor cell plasticity inuveal melanoma: microenvironment directed dampening ofthe invasive and metastatic genotype and phenotypeaccompanies the generation of vasculogenic mimicrypatterns. Am J Pathol 2006; 169: 1376-89.
61. Nikolova G, Strilic B, Lammert E. The vascular niche and itsbasement membrane. Trends Cell Biol 2007; 17: 19-25.
62. Shen Q, Goderie SK, Jin L, et al. Endothelial cells stimulateself-renewal and expand neurogenesis of neural stem cells. Science 2004; 304: 1338-40.
63. Avecilla ST, Hattori K, Heissig B, et al. Chemokine-mediatedinteraction of hematopoietic progenitors with the bonemarrow vascular niche is required for thrombopoiesis. Nat Med 2004; 10: 64-71.
64. Calavrese C, Poppleton H, Kocak M, et al. A perivascularniche for brain tumor stem cells. Cancer Cell 2007; 11: 69-82.
65. Gilbertson RJ, Rich JN. Making a tumor's bed: glioblastomastem cells and the vascular niche. Nature 2007; 7: 733-6.
66. Bian XW, Wang QL, Xiao HL, Wang JM. Tumormicrovascular architecture phenotype (T-MAP) as a newconcept for studies of angiogenesis and oncology. JNeurooncol 2006; 80: 211-3.
67. Borovski T, Verhoeff JJ, ten Cate R, et al. Tumormicrovasculature supports proliferation and expansion ofglioma-propagating cells. Int J Cancer 2009; 125: 1222-30.
68. Rak J, Milsom C, Yu J. Vascular determinants of cancerstem cell dormancy-do age and coagulation system play arole? APMIS 2008; 116: 660-76.
69. Priceman SJ, Sung JL, Shaposhnik Z, et al. Targetingdistinct-infiltrating myeloid cells by inhibiting CSF-1 receptorcombating tumor evasion of anti-angiogenic therapy. Blood 2010; 115: 1461-71.
70. Koukourakis MI, Giatromanolaki A, Sheldon H, et al. Phase I/II trial of bevacizumab and radiotherapy for locallyadvanced inoperable colorectal cancer: vasculatureindependentradiosensitizing effect of bevacizumab. Clin Cancer Res 2009; 15: 7069-76.
71. Ito K, Bernardi R, Morotti A, et al. PML targeting eradicatesquiescent leukaemia-initiating cells. Nature 2008; 453: 1072-8.